Opthea Ltd-spon Adr logo

Opthea Ltd-spon Adr (OPT) live share price

Opthea Ltd-spon Adr share price in USD $3.69 & INR ₹312.52

$3.69

▲

0.36

(10.81%)

View live Opthea Ltd-spon Adr share price in Dollar and Rupees. Guide to invest in Opthea Ltd-spon Adr from India. Also see the sentimental analysis on Indian investors investing in Opthea Ltd-spon Adr. Get details on the Indian mutual funds that are investing in Opthea Ltd-spon Adr. Get Analyst recommendations and forecasts along with all the Opthea Ltd-spon Adr's financials.

Opthea Ltd-spon Adr share price movements

  • $3.35
    $3.69

    Day's Volatility :9.21%

  • $1.79
    $5.45

    52 Weeks Volatility :67.16%

Opthea Ltd-spon Adr Returns

PeriodOpthea Ltd-spon AdrSector (Health Care)Index (Russel 2000)
3 Months
26.8%
-6.2%
0.0%
6 Months
38.72%
2.6%
0.0%
1 Year
42.47%
11.8%
0.0%
3 Years
-40.48%
13.3%
-19.8%

Opthea Ltd-spon Adr Key Statistics

in dollars & INR

Market Capitalization
$543.9M
Revenue TTM
$261.9K
EBITDA
$-191.8M
Earnings Per Share (EPS)
$-2.76
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-3383.08%

How to invest in Opthea Ltd-spon Adr from India?

It is very easy for Indian residents to invest directly in Opthea Ltd-spon Adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Opthea Ltd-spon Adr stock in both rupees (INR) and dollars (USD). Search for Opthea Ltd-spon Adr or OPT on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Opthea Ltd-spon Adr or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Opthea Ltd-spon Adr shares which would translate to 0.230 fractional shares of Opthea Ltd-spon Adr as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Opthea Ltd-spon Adr

75%

Period: Sep 2, 2024 to Dec 1, 2024. Change in 30 Days versus previous period

Search volume for Opthea Ltd-spon Adr on INDmoney from India has grown in the last 30 days as on Dec 2, 2024. 75% more investors are searching Opthea Ltd-spon Adr in the last 30 days versus the previous period.

Global Institutional Holdings in Opthea Ltd-spon Adr

  • VGI PARTNERS PTY Ltd

    1.89%

  • Baker Bros Advisors LP

    1.41%

  • Millennium Management LLC

    0.05%

  • Bank of Montreal

    0.03%

  • BMO Capital Markets Corp.

    0.03%

  • Stratos Wealth Partners, LTD

    0.02%

Analyst Recommendation on Opthea Ltd-spon Adr

Sell

    11%Buy

    33%Hold

    55%Sell

Based on 9 Wall street analysts offering stock ratings for Opthea Ltd-spon Adr(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
1
1
2
Hold
3
2
2
Sell
5
6
6

Analyst Forecast on Opthea Ltd-spon Adr

What analysts predicted

Upside of 229.72%

Current:

$3.69

Target:

$12.17

Insights on Opthea Ltd-spon Adr

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 93.18K → 63.83K (in $), with an average decrease of 31.5% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -147.41M → -123.99M (in $), with an average increase of 18.9% per quarter

  • Vs VRTX

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.4% return, outperforming this stock by 80.4%

Opthea Ltd-spon Adr Financials in INR & Dollars

FY19Y/Y Change
Revenue
$78.2K
-
Net Income
$-10.4M
↑ 20.44%
Net Profit Margin
-13.3K%
-
FY20Y/Y Change
Revenue
$40.7K
↓ 47.5%
Net Income
$-7.6M
↓ 25.9%
Net Profit Margin
-18.8K%
↓ 5468.89%
FY21Y/Y Change
Revenue
$70.2K
↑ 55.74%
Net Income
$-46.4M
↑ 448.59%
Net Profit Margin
-66.1K%
↓ 47325.99%
FY22Y/Y Change
Revenue
$87.9K
↑ 35.95%
Net Income
$-90.0M
↑ 110.55%
Net Profit Margin
-102.4K%
↓ 36266.11%
FY23Y/Y Change
Revenue
$108.3K
↑ 28.88%
Net Income
$-142.3M
↑ 65.54%
Net Profit Margin
-131.5K%
↓ 29116.11%
FY24Y/Y Change
Revenue
$124.7K
↓ 22.65%
Net Income
$-220.2M
↑ 3.95%
Net Profit Margin
-176.7K%
↓ 45195.93%
Q3 FY22Q/Q Change
Revenue
$154.1K
↑ 133.08%
Net Income
$-60.3M
↓ 24.48%
Net Profit Margin
-39.1K%
↑ 81628.83%
Q4 FY22Q/Q Change
Revenue
$77.8K
↓ 49.5%
Net Income
$-115.1M
↑ 90.98%
Net Profit Margin
-148.0K%
↓ 108840.57%
Q1 FY23Q/Q Change
Revenue
$140.8K
↑ 80.94%
Net Income
$-48.9M
↓ 57.49%
Net Profit Margin
-34.8K%
↑ 113203.15%
Q2 FY23Q/Q Change
Revenue
$83.3K
↓ 40.79%
Net Income
$-96.8M
↑ 97.92%
Net Profit Margin
-116.2K%
↓ 81444.87%
Q4 FY23Q/Q Change
Revenue
$93.2K
↑ 11.81%
Net Income
$-147.4M
↑ 52.22%
Net Profit Margin
-158.2K%
↓ 41999.78%
Q2 FY24Q/Q Change
Revenue
$63.8K
↓ 31.49%
Net Income
$-124.0M
↓ 15.89%
Net Profit Margin
-194.2K%
↓ 36036.23%
FY19Y/Y Change
Total Assets
$12.8M
↓ 45.38%
Total Liabilities
$2.2M
↓ 44.7%
FY20Y/Y Change
Total Assets
$23.6M
↑ 85.3%
Total Liabilities
$2.3M
↑ 5.06%
FY21Y/Y Change
Total Assets
$140.8M
↑ 438.21%
Total Liabilities
$3.2M
↑ 23.34%
FY22Y/Y Change
Total Assets
$61.4M
↓ 52.64%
Total Liabilities
$12.3M
↑ 321.89%
FY23Y/Y Change
Total Assets
$99.6M
↑ 69.7%
Total Liabilities
$105.5M
↑ 794.37%
FY24Y/Y Change
Total Assets
$188.8M
↑ 27.4%
Total Liabilities
$264.6M
↑ 68.56%
Q3 FY22Q/Q Change
Total Assets
$240.8M
↑ 301.01%
Total Liabilities
$152.5M
↑ 1163.54%
Q4 FY22Q/Q Change
Total Assets
$153.3M
↓ 5.69%
Total Liabilities
$97.1M
↓ 5.69%
Q1 FY23Q/Q Change
Total Assets
$147.5M
↓ 35.03%
Total Liabilities
$156.3M
↑ 8.67%
Q2 FY23Q/Q Change
Total Assets
$99.6M
↑ 0.43%
Total Liabilities
$105.5M
↑ 0.43%
Q4 FY23Q/Q Change
Total Assets
$166.5M
↑ 12.36%
Total Liabilities
$213.4M
↑ 35.95%
Q2 FY24Q/Q Change
Total Assets
$188.8M
↑ 13.39%
Total Liabilities
$264.6M
↑ 23.98%
FY19Y/Y Change
Operating Cash Flow
$-8.3M
↓ 40.25%
Investing Cash Flow
$223.0K
↓ 1032.61%
Financing Cash Flow
$4.3M
↑ 1431.36%
FY20Y/Y Change
Operating Cash Flow
$-3.9M
↓ 52.24%
Investing Cash Flow
$328.2K
↑ 48.22%
Financing Cash Flow
$23.2M
↑ 444.31%
FY21Y/Y Change
Operating Cash Flow
$-46.6M
↑ 973.15%
Investing Cash Flow
$501.4K
↑ 37.99%
Financing Cash Flow
$119.7M
↑ 365.79%
FY22Y/Y Change
Operating Cash Flow
$-69.1M
↑ 61.1%
Investing Cash Flow
$-11.9K
↓ 102.58%
Financing Cash Flow
$166.3K
↓ 99.85%
FY23Y/Y Change
Operating Cash Flow
$-120.5M
↑ 82.28%
Investing Cash Flow
$-14.7K
↑ 29.83%
Financing Cash Flow
$167.1M
↑ 105002.38%
Q3 FY22Q/Q Change
Operating Cash Flow
$-54.2M
↓ 12.18%
Investing Cash Flow
$-3.5K
↓ 53.99%
Financing Cash Flow
$130.7M
↓ 226477.28%
Q4 FY22Q/Q Change
Operating Cash Flow
$-103.4M
↑ 90.98%
Investing Cash Flow
$-3.5K
↑ 0.0%
Financing Cash Flow
$249.6M
↑ 90.98%
Q1 FY23Q/Q Change
Operating Cash Flow
$-38.4M
↓ 62.89%
Investing Cash Flow
$-7.5K
↑ 112.74%
Financing Cash Flow
$67.3K
↓ 99.97%
Q2 FY23Q/Q Change
Operating Cash Flow
$-75.1M
↑ 95.63%
Investing Cash Flow
$-7.5K
↑ 0.0%
Financing Cash Flow
$-2.0M
↓ 3052.2%

Opthea Ltd-spon Adr Technicals Summary

Sell

Neutral

Buy

Opthea Ltd-spon Adr is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Opthea Ltd-spon Adr Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Opthea Ltd-spon Adr
Opthea Ltd-spon Adr
-12.35%
38.72%
42.47%
-40.48%
-70.0%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-9.49%
-24.18%
-8.88%
18.12%
102.78%
Biontech Se
Biontech Se
8.64%
15.09%
18.5%
-65.59%
454.0%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
-6.25%
68.21%
46.39%
47.68%
107.47%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
-0.99%
-0.44%
33.51%
129.69%
109.07%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Opthea Ltd-spon Adr
Opthea Ltd-spon Adr
NA
NA
NA
-12.19
-33.83
-0.83
NA
-0.07
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
18.66
18.66
1.12
44.91
0.17
0.07
NA
272.04
Biontech Se
Biontech Se
160.8
NA
0.04
-3.06
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
32.84
NA
1.22
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Opthea Ltd-spon Adr
Opthea Ltd-spon Adr
Sell
$543.9M
-70.0%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$83.0B
102.78%
18.66
33.61%
Biontech Se
Biontech Se
Buy
$28.9B
454.0%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Buy
$32.7B
107.47%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$119.6B
109.07%
32.84
-4.51%

About Opthea Ltd-spon Adr

opthea limited (formerly circadian technologies) is a public australian biotechnology company developing novel biologic therapies for the treatment of eye diseases. opthea's lead compound, opt-302, blocks two members of the vascular endothelial growth factor family, namely vegf-c and vegf-d, which cause blood vessels to grow and leak. aberrant blood vessel growth and vascular leakage are hallmarks of several eye diseases including wet age-related macular degeneration (wet amd). opthea is currently investigating opt-302 in an ongoing phase 1/2a clinical trial in wet amd patients. enquiries can be directed to: info@opthea.com
Organization
Opthea Ltd-spon Adr
Employees
33
CEO
Dr. Frederic Guerard M.S., Pharm.D.
Industry
Health Technology

Important FAQs about investing in Opthea Ltd-spon Adr from India :

What is Opthea Ltd-spon Adr share price today?

Opthea Ltd-spon Adr (OPT) share price today is $3.69.

Can Indians buy Opthea Ltd-spon Adr shares?

Yes, Indians can invest in the Opthea Ltd-spon Adr (OPT) from India.

With INDmoney, you can buy Opthea Ltd-spon Adr at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Opthea Ltd-spon Adr at zero transaction cost.

How can I buy Opthea Ltd-spon Adr shares from India?

It is very easy to buy Opthea Ltd-spon Adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Opthea Ltd-spon Adr be purchased?

Yes, you can buy fractional shares of Opthea Ltd-spon Adr with INDmoney app.

What are the documents required to start investing in Opthea Ltd-spon Adr stocks?

To start investing in Opthea Ltd-spon Adr, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Opthea Ltd-spon Adr

Today’s highest price of Opthea Ltd-spon Adr (OPT) is $3.69.

Today’s lowest price of Opthea Ltd-spon Adr (OPT) is $3.35.

What is today's market capitalisation of Opthea Ltd-spon Adr

Today's market capitalisation of Opthea Ltd-spon Adr OPT is 543.9M

What is the 52 Week High and Low Range of Opthea Ltd-spon Adr

  • 52 Week High

    $5.45

  • 52 Week Low

    $1.79

How much percentage Opthea Ltd-spon Adr is down from its 52 Week High?

Opthea Ltd-spon Adr (OPT) share price is $3.69. It is down by 99% from its 52 Week High price of $5.45.

How much percentage Opthea Ltd-spon Adr is up from its 52 Week low?

Opthea Ltd-spon Adr (OPT) share price is $3.69. It is up by 1% from its 52 Week Low price of $1.79.

What are the historical returns of Opthea Ltd-spon Adr?

  • 1 Month Returns

    -12.35%

  • 3 Months Returns

    38.72%

  • 1 Year Returns

    42.47%

  • 5 Years Returns

    -70%

Who is the Chief Executive Officer (CEO) of Opthea Ltd-spon Adr

Dr. Frederic Guerard M.S., Pharm.D. is the current Chief Executive Officer (CEO) of Opthea Ltd-spon Adr.